Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 13/20 | 0.61 |
| ▸ | LPAR2 | Q9HBW0 | 9/20 | 0.61 |
| ▸ | LPAR1 | Q92633 | 6/20 | 0.61 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.41 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.41 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.41 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 0.41 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.38 |
| ▸ | IGF2R | P11717 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4533132 | 1.00 | LPAR3 (0.61) | LPAR3LPAR2LPAR1CSNK2A2CSNK2B | |
| SCHEMBL4524621 | 1.00 | LPAR3 (0.61) | LPAR3LPAR2LPAR1CSNK2A2CSNK2B | |
| SCHEMBL4533011 | 1.00 | LPAR3 (0.61) | LPAR3LPAR2LPAR1CSNK2A2CSNK2B | |
| SCHEMBL4529368 | 1.00 | LPAR3 (0.61) | LPAR3LPAR2LPAR1CSNK2A2CSNK2B | |
| SCHEMBL4531294 | 1.00 | LPAR3 (0.61) | LPAR3LPAR2LPAR1CSNK2A2CSNK2B | |
| SCHEMBL4533510 | 1.00 | LPAR3 (0.61) | LPAR3LPAR2LPAR1CSNK2A2CSNK2B | |
| SCHEMBL4531849 | 1.00 | LPAR3 (0.61) | LPAR3LPAR2LPAR1CSNK2A2CSNK2B | |
| SCHEMBL4532319 | 1.00 | LPAR3 (0.61) | LPAR3LPAR2LPAR1CSNK2A2CSNK2B | |
| SCHEMBL4536728 | 1.00 | LPAR3 (0.61) | LPAR3LPAR2LPAR1CSNK2A2CSNK2B | |
| SCHEMBL4538235 | 1.00 | LPAR3 (0.61) | LPAR3LPAR2LPAR1CSNK2A2CSNK2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090123516-A1 | DRUG DELIVERY FROM IMPLANTS USING SELF-ASSEMBLED MONOLAYERS-THERAPEUTIC SAMS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2009-05-14 | — | — | US | disclosed |
| WO-2007019478-A2 | DRUG DELIVERY FROM IMPLANTS USING SELF-ASSEMBLED MONOLAYERS - THERAPEUTIC SAMS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2007-02-15 | — | — | WO | disclosed |